Literature DB >> 22007938

Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters.

Agnese Proietti1, Clara Ugolini, Rosa Marina Melillo, Giuliana Crisman, Rossella Elisei, Massimo Santoro, Michele Minuto, Paolo Vitti, Paolo Miccoli, Fulvio Basolo.   

Abstract

BACKGROUND: In a number of human malignancies, the presence of lymphocytic infiltration in or around tumor tissue is commonly considered to be part of the host tumor immune response. An association between thyroid carcinoma and chronic inflammation has been described. This relationship is not fully understood, so we performed a systematic study on a follicular variant of papillary thyroid carcinoma (FVPTC), to evaluate the type and distribution of certain immunological cells and their relationship with prognostic factors.
METHODS: We selected 91 consecutive cases of FVPTC, in which we evaluated the presence of three different immunological cells: dendritic cells (DC), immature CD1a+ and mature DC-Lamp+; mast cells (MC), tryptase+; and macrophages (M), CD68+, in the intratumoral, peritumoral, and extratumoral areas. As a control we analyzed 44 cases of thyroid adenomas (A).
RESULTS: In the intratumoral and peritumoral areas, the expression of CD1a, tryptase, and CD68 was significantly higher in FVPTC than in adenomas. Expression of CD1a and tryptase was comparable in the extratumoral compartment, whereas CD68 expression in the extratumoral area was significantly higher in FVPTC than in adenoma (p=0.0015). DC-Lamp expression was not significantly different among the intra-tumor, peri-tumor, and extra-tumor areas of FVPTC or adenoma. It was also very interesting that nonencapsulated FVPTC were more positive to tryptase.
CONCLUSION: We highlight a higher presence of immunological cells in carcinomas than in adenomas. On this basis, it is possible to speculate that these inflammatory elements could be involved in tumor progression and invasion, as appears to be the case for MC and M.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22007938     DOI: 10.1089/thy.2011.0059

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  17 in total

Review 1.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

2.  Positive effect of RORγt on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto's thyroiditis.

Authors:  Rong Zeng; Yi Lyu; Guoqiao Zhang; Tao Shou; Kai Wang; Heng Niu; Xinmin Yan
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

3.  ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation.

Authors:  Flavia Magri; Valentina Capelli; Margherita Gaiti; Laura Villani; Francesca Zerbini; Luigi La Manna; Mario Rotondi; Luca Chiovato
Journal:  Endocrine       Date:  2014-10-22       Impact factor: 3.633

4.  Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.

Authors:  Tara Jarboe; Neha Y Tuli; Sanjukta Chakraborty; Rachana R Maniyar; Nicole DeSouza; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer.

Authors:  Yuxiao Xia; Xue Jiang; Yuan Huang; Qian Liu; Yin Huang; Bo Zhang; Zhanjun Mei; Dongkun Xu; Yuhong Shi; Wenling Tu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-08       Impact factor: 6.055

6.  Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.

Authors:  Andrey Bychkov; Vladimir Saenko; Masahiro Nakashima; Norisato Mitsutake; Tatiana Rogounovitch; Alyaksandr Nikitski; Florence Orim; Shunichi Yamashita
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

Review 7.  Immune Landscape of Thyroid Cancers: New Insights.

Authors:  Elisa Menicali; Martina Guzzetti; Silvia Morelli; Sonia Moretti; Efisio Puxeddu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-27       Impact factor: 5.555

Review 8.  Tumor-Associated Mast Cells in Thyroid Cancer.

Authors:  Carla Visciano; Nella Prevete; Federica Liotti; Gianni Marone
Journal:  Int J Endocrinol       Date:  2015-08-26       Impact factor: 3.257

Review 9.  Immune response in thyroid cancer: widening the boundaries.

Authors:  Laura Sterian Ward
Journal:  Scientifica (Cairo)       Date:  2014-09-25

10.  Distribution of subpopulations of dendritic cells in peripheral blood of patients treated with exogenous thyrotropin.

Authors:  Mariusz Stasiołek; Zbigniew Adamczewski; Bartosz Puła; Kinga Krawczyk-Rusiecka; Arkadiusz Zygmunt; Magdalena Borowiecka; Piotr Dzięgiel; Andrzej Lewiński
Journal:  Thyroid Res       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.